Skip to main content
TipRanks
Go Ultimate75% OFF

Livzon Pharmaceutical Group (LP6) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

LP6 Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Livzon Pharmaceutical Group in the past 3 months

LP6 Stock 12 Month Forecast

€3.94▲(47.01% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Livzon Pharmaceutical Group in the last 3 months. The average price target is EUR 3.94 with a high forecast of EUR 4.23 and a low forecast of EUR 3.65. The average price target represents a 47.01% change from the last price of EUR 2.68.
Highest Price Target€4.23Average Price Target€3.94Lowest Price Target€3.65

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:LP6
Price TargetArticle
CICC Analyst forecast on DE:LP6Unknown AnalystNot RankedCICC€3.65buy36.11%UpsideReiterated10/28/26
Citi Analyst forecast on DE:LP6Unknown AnalystNot RankedCiti€4.23buy57.90%UpsideReiterated08/27/26
HSBC Analyst forecast on DE:LP6Unknown AnalystNot RankedHSBC€3.33hold24.44%UpsideReiterated07/10/26
Goldman Sachs€3.10→€2.64sell-1.35%DownsideDowngraded02/05/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Livzon Pharmaceutical Group

3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
+0.10%

Copying OpenAI Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.10% per trade.

1 Year
Success Rate1/2 ratings generated profit
50%
Average Return
+2.05%

Copying xAi Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.05% per trade.

2 Years
Success Rate1/2 ratings generated profit
50%
Average Return
+2.05%

Copying xAi Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +2.05% per trade.

LP6 Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for LP6
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy01121
Hold11100
Sell00000
Strong Sell00000
total12221

In the current month, LP6 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LP6 average Analyst price target in the past 3 months is 3.94.

LP6 Financial Forecast

€-1€-0.5€0€0.5€1Q1 2026Q3 2026Q4 2026
High€0.05
Consensus€0.05
Low€0.05

LP6 Earnings Forecast

Next quarter’s earnings estimate for LP6 is EUR 0.05 with a range of EUR 0.05 to EUR 0.05. The previous quarter’s EPS was EUR 0.05. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

€278.3M€300.7M€323.2M€345.6M€368MQ1 2026Q3 2026Q4 2026
High€313M
Consensus€313M
Low€313M

LP6 Sales Forecast

Next quarter’s sales forecast for LP6 is EUR 313.47M with a range of EUR 313.47M to EUR 313.47M. The previous quarter’s sales results were EUR 306.51M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

LP6 Stock Forecast FAQ

What is DE:LP6’s average 12-month price target, according to analysts?
Based on analyst ratings, Livzon Pharmaceutical Group’s 12-month average price target is €3.94.
What is DE:LP6’s upside potential, based on the analysts’ average price target?
Livzon Pharmaceutical Group has 47.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Livzon Pharmaceutical Group a Buy, Sell or Hold?
Livzon Pharmaceutical Group has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Livzon Pharmaceutical Group’s share price target?
The average share price target for Livzon Pharmaceutical Group is €3.94. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €4.23, and the lowest forecast is €3.65. The average share price target represents a 47.01% increase from the current price of €2.68.
What do analysts say about Livzon Pharmaceutical Group?
Livzon Pharmaceutical Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Livzon Pharmaceutical Group?
To buy shares of DE:LP6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.